Articles with public access mandates - Jodi B SegalLearn more
Not available anywhere: 12
Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children
JJ Strouse, S Lanzkron, MC Beach, C Haywood, H Park, C Witkop, ...
Pediatrics 122 (6), 1332-1342, 2008
Mandates: US National Institutes of Health
Evaluating health outcomes in the presence of competing risks: a review of statistical methods and clinical applications
R Varadhan, CO Weiss, JB Segal, AW Wu, D Scharfstein, C Boyd
Medical care 48 (6), S96-S105, 2010
Mandates: US National Institutes of Health
A systematic review of mandatory influenza vaccination in healthcare personnel
SI Pitts, NM Maruthur, KR Millar, TM Perl, J Segal
American journal of preventive medicine 47 (3), 330-340, 2014
Mandates: US National Institutes of Health
Pharmacologic and mechanical strategies for preventing venous thromboembolism after bariatric surgery: a systematic review and meta-analysis
DJ Brotman, HM Shihab, KR Prakasa, S Kebede, ER Haut, R Sharma, ...
JAMA surgery 148 (7), 675-686, 2013
Mandates: US National Institutes of Health
Strategies to prevent weight gain in adults: a systematic review
S Hutfless, KA Gudzune, N Maruthur, RF Wilson, SN Bleich, BD Lau, ...
American journal of preventive medicine 45 (6), e41-e51, 2013
Mandates: US National Institutes of Health
Identifying and prioritizing the barriers and facilitators to the self-management of type 2 diabetes mellitus: a community-centered approach
AH Oakes, VS Garmo, LR Bone, DR Longo, JB Segal, JFP Bridges
The Patient-Patient-Centered Outcomes Research 10, 773-783, 2017
Mandates: Patient-Centered Outcomes Research Institute
Understanding geographic variation in systemic overuse among the privately insured
AH Oakes, AP Sen, JB Segal
Medical care 58 (3), 257-264, 2020
Mandates: US National Institutes of Health
Ultra-Expensive Drugs And Medicare Part D: Spending And Beneficiary Use Up Sharply: Study examines Medicare Part D spending for and beneficiary use of ultra-expensive drugs.
SY Kang, D Polsky, JB Segal, GF Anderson
Health Affairs 40 (6), 1000-1005, 2021
Mandates: Arnold Ventures LLC
Reducing overuse by healthcare systems: a positive deviance analysis
MI Ellenbogen, AA Wiegand, JM Austin, NL Schoenborn, N Kodavarti, ...
Journal of general internal medicine 38 (11), 2519-2526, 2023
Mandates: US National Institutes of Health
Formulary restrictions may impact enrollment in pragmatic trials and limit generalizability of findings to vulnerable populations
JB Segal, PRIORITIZE HCV Study Group
Clinical Trials 17 (6), 729-731, 2020
Mandates: Patient-Centered Outcomes Research Institute
Frailty measurement using administrative data in older patients with cardiovascular disease
AA Damluji, G Gerstenblith, JB Segal
JAMA cardiology 5 (8), 967-968, 2020
Mandates: US National Institutes of Health, American Heart Association
Efficacy of Sublingual Immunotherapy—Reply
SY Lin, C Suarez-Cuervo, J Segal
JAMA 310 (6), 644-645, 2013
Mandates: National Institute of Health and Medical Research, France
Available somewhere: 127
Comparative effectiveness and safety of medications for type 2 diabetes: an update including new drugs and 2-drug combinations
WL Bennett, NM Maruthur, S Singh, JB Segal, LM Wilson, R Chatterjee, ...
Annals of internal medicine 154 (9), 602-613, 2011
Mandates: US National Institutes of Health
Oral direct-acting agent therapy for hepatitis C virus infection: a systematic review
O Falade-Nwulia, C Suarez-Cuervo, DR Nelson, MW Fried, JB Segal, ...
Annals of internal medicine 166 (9), 637-648, 2017
Mandates: US National Institutes of Health, Patient-Centered Outcomes Research Institute
What childhood obesity prevention programmes work? A systematic review and meta‐analysis
Y Wang, L Cai, Y Wu, RF Wilson, C Weston, O Fawole, SN Bleich, ...
Obesity reviews 16 (7), 547-565, 2015
Mandates: US National Institutes of Health, National Institute for Health Research, UK
Glucagonlike peptide 1–based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study
S Singh, HY Chang, TM Richards, JP Weiner, JM Clark, JB Segal
JAMA internal medicine 173 (7), 534-539, 2013
Mandates: US National Institutes of Health
Systematic review of community-based childhood obesity prevention studies
SN Bleich, J Segal, Y Wu, R Wilson, Y Wang
Pediatrics 132 (1), e201-e210, 2013
Mandates: US National Institutes of Health
Systematic review: Hydroxyurea for the treatment of adults with sickle cell disease
S Lanzkron, JJ Strouse, R Wilson, MC Beach, C Haywood, HS Park, ...
Annals of internal medicine 148 (12), 939-955, 2008
Mandates: US National Institutes of Health
Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review
JB Segal, DJ Brotman, AJ Necochea, A Emadi, L Samal, LM Wilson, ...
Jama 301 (23), 2472-2485, 2009
Mandates: US National Institutes of Health
Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review
SY Lin, N Erekosima, JM Kim, M Ramanathan, C Suarez-Cuervo, ...
Jama 309 (12), 1278-1288, 2013
Mandates: US National Institutes of Health
Publication and funding information is determined automatically by a computer program